Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update

Go back to Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update
(NASDAQ: SNDX) Delayed: 18.25 +0.34 (1.90%)
Previous Close $17.91    52 Week High $18.03 
Open $18.05    52 Week Low $8.97 
Day High $18.33    P/E N/A 
Day Low $17.74    EPS $0.00 
Volume 1,048,625